Literature DB >> 29266076

ACOG Practice Bulletin No. 189: Nausea And Vomiting Of Pregnancy.

.   

Abstract

Nausea and vomiting of pregnancy is a common condition that affects the health of a pregnant woman and her fetus. It can diminish a woman's quality of life and also significantly contributes to health care costs and time lost from work (1, 2). Because morning sickness is common in early pregnancy, the presence of nausea and vomiting of pregnancy may be minimized by obstetricians, other obstetric care providers, and pregnant women and, thus, undertreated (1). Furthermore, some women do not seek treatment because of concerns about the safety of medications (3). Once nausea and vomiting of pregnancy progresses, it can become more difficult to control symptoms. Treatment in the early stages may prevent more serious complications, including hospitalization (4). Safe and effective treatments are available for more severe cases, and mild cases of nausea and vomiting of pregnancy may be resolved with lifestyle and dietary changes. The woman's perception of the severity of her symptoms plays a critical role in the decision of whether, when, and how to treat nausea and vomiting of pregnancy. Nausea and vomiting of pregnancy should be distinguished from nausea and vomiting related to other causes. The purpose of this document is to review the best available evidence about the diagnosis and management of nausea and vomiting of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29266076     DOI: 10.1097/AOG.0000000000002456

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  21 in total

1.  Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009-2016.

Authors:  Kelly C Young-Wolff; Varada Sarovar; Lue-Yen Tucker; Lyndsay A Avalos; Stacey Alexeeff; Amy Conway; Mary Anne Armstrong; Constance Weisner; Cynthia I Campbell; Nancy Goler
Journal:  Drug Alcohol Depend       Date:  2019-01-18       Impact factor: 4.492

Review 2.  Emergent MRI for acute abdominal pain in pregnancy-review of common pathology and imaging appearance.

Authors:  Arafat Ali; Katrina Beckett; Carl Flink
Journal:  Emerg Radiol       Date:  2020-01-05

Review 3.  The Pregnant Surgeon.

Authors:  Cristina R Harnsberger; Jennifer S Davids
Journal:  Clin Colon Rectal Surg       Date:  2019-08-22

4.  Antiemetic treatment of hyperemesis gravidarum in 1,064 Norwegian women and the impact of European warning on metoclopramide: a retrospective cohort study 2002-2019.

Authors:  Hilde Erdal; Lone Holst; Kristine Heitmann; Jone Trovik
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-02       Impact factor: 3.105

5.  Impact of a Mobile Application for Tracking Nausea and Vomiting During Pregnancy (NVP) on NVP Symptoms, Quality of Life, and Decisional Conflict Regarding NVP Treatments: MinSafeStart Randomized Controlled Trial.

Authors:  Elin Ngo; Maria Bich-Thuy Truong; Hedvig Nordeng; David Wright
Journal:  JMIR Mhealth Uhealth       Date:  2022-07-05       Impact factor: 4.947

6.  Prescription and Other Medication Use in Pregnancy.

Authors:  David M Haas; Derek J Marsh; Danny T Dang; Corette B Parker; Deborah A Wing; Hyagriv N Simhan; William A Grobman; Brian M Mercer; Robert M Silver; Matthew K Hoffman; Samuel Parry; Jay D Iams; Steve N Caritis; Ronald J Wapner; M Sean Esplin; Michal A Elovitz; Alan M Peaceman; Judith Chung; George R Saade; Uma M Reddy
Journal:  Obstet Gynecol       Date:  2018-05       Impact factor: 7.661

7.  Ondansetron use in the first trimester of pregnancy and the risk of neonatal ventricular septal defect.

Authors:  Lara S Lemon; Lisa M Bodnar; William Garrard; Raman Venkataramanan; Robert W Platt; Oscar C Marroquin; Steve N Caritis
Journal:  Int J Epidemiol       Date:  2020-04-01       Impact factor: 7.196

8.  Rating of four different foods in women with hyperemesis gravidarum: a randomised controlled trial.

Authors:  Gi Ni Tan; Peng Chiong Tan; Jesrine Gek Shan Hong; Balaraman Kartik; Siti Zawiah Omar
Journal:  BMJ Open       Date:  2021-05-13       Impact factor: 2.692

9.  Repurposing chlorpromazine to treat COVID-19: The reCoVery study.

Authors:  M Plaze; D Attali; A-C Petit; M Blatzer; E Simon-Loriere; F Vinckier; A Cachia; F Chrétien; R Gaillard
Journal:  Encephale       Date:  2020-05-16       Impact factor: 1.291

10.  Pyridoxine for prevention and treatment of PARP inhibitor induced nausea and vomiting.

Authors:  Stuart A Ostby; Haller J Smith; Charles A Leath
Journal:  Gynecol Oncol Rep       Date:  2019-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.